Orthobiologics

Anika Therapeutics completed enrollment in its second pivotal Phase III trial evaluating CINGAL® HA/corticosteroid viscosupplement for the treatment of knee...

Cerapedics’ i-FACTOR™ Peptide Enhanced Bone Graft is now in use at >150 U.S. hospitals....

LifeNet Health introduced PliaFX® Strip allograft, comprising 100% cortical bone fibers, to be available in 1H18....

Artoss introduced NanoBone® QD bone graft, comprising NanoBone SBX putty in an application designed for quick delivery....

FzioMed received FDA approval to conduct a small confirmatory study of Oxiplex® synthetic viscoelastic gel, examining its use following lumbar surgery....

Anika Therapeutics received Australia regulatory approval to market MONOVISC® single-injection viscosupplement for the treatment of osteoarthritis pain in all synovial joints. ...

Vivorté launched FORTERA™ and REGENTO™ bone graft products for orthopaedic surgery....

FDA accepted DiscGenics’ Investigational New Drug Application for a clinical study of its cell therapy product candidate to treat degenerative disc disease....

CartiHeal enrolled and treated 16 patients in its IDE study of Agili-C™ implants in the treatment of joint surface lesions. ...

Subchondral Solutions received FDA 510(k) clearance to market the fenestrated, cannulated S4 Screw System™ to treat osteochondral fractures....